Business Highlights in Q4
Resulting from Philips’ continuous investments in innovation, the company has received 510(k) clearance from the Food and Drug Administration (FDA) to market its whole body PET/MR imaging system, the Ingenuity TF PET/MR, and its HeartNavigator interventional tool in the US. In addition, the company has introduced the next generation mammography solution, Philips MicroDose, in the US.
Philips completed the acquisition of Povos, a leading kitchen appliance company in China, significantly stepping up its position in the market and enhancing its local and global business creation capabilities.
Philips’ acquisition of Indal, a leading professional luminaires company based in Spain, has been approved by regulatory authorities and is now closed. With this acquisition, Philips will further strengthen its position and fuel growth in European outdoor lighting solutions.
|